Hjem › Lungekreft › Arizona › Tucson
Kliniske studier for Lungekreft i Tucson, AZ
9 studier for Lungekreft søker deltakere på steder i og rundt Tucson (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Registry for People With Lung Cancer
RekruttererObservasjonsstudie
- University of Arizona (Data Collection Only), Tucson
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
RekruttererFase 2/3
- University of Arizona Cancer Center, Tucson
Social Optimization Study
Rekrutterer
- University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekruttererFase 3
- ACRC Arizona Clinical Research Center, Tucson
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruttererFase 3
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Arizona Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- The University of Arizona Cancer Center, Tucson
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Arlington, VA41 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Baltimore, MD40 studier
- Nashville, TN40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Tucson
- Brystkreft20 studier
- Fedme18 studier
- Ikke-småcellet lungekreft17 studier
- Overvekt15 studier
- Metastatisk kreft14 studier
- Kreft (alle typer)12 studier
- Kardiovaskulær sykdom12 studier
- Kolorektal kreft11 studier
- Prostatakreft11 studier
- Type 2-diabetes11 studier
- Steatotisk leversykdom10 studier
- Hjertesvikt10 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.